Showing 601 - 620 results of 3,656 for search '(( significantly ((teer decrease) OR (mean decrease)) ) OR ( significantly larger decrease ))', query time: 0.48s Refine Results
  1. 601
  2. 602
  3. 603

    Study Data. by Jonathan S. Jahr (2709088)

    Published 2025
    “…It has also been hypothesized that the bradycardia and rare instances of cardiac arrest occurring after the use of sugammadex may be due to a transient decrease in circulating corticosteroids, causing a temporary ‘mini Addisonian crisis.’ …”
  4. 604

    Study outcomes. by Jonathan S. Jahr (2709088)

    Published 2025
    “…It has also been hypothesized that the bradycardia and rare instances of cardiac arrest occurring after the use of sugammadex may be due to a transient decrease in circulating corticosteroids, causing a temporary ‘mini Addisonian crisis.’ …”
  5. 605

    Patient characteristics. by Jonathan S. Jahr (2709088)

    Published 2025
    “…It has also been hypothesized that the bradycardia and rare instances of cardiac arrest occurring after the use of sugammadex may be due to a transient decrease in circulating corticosteroids, causing a temporary ‘mini Addisonian crisis.’ …”
  6. 606
  7. 607
  8. 608
  9. 609
  10. 610
  11. 611
  12. 612
  13. 613

    <b> </b> Rate of brain weight to body weight in different experimental groups. AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate.... by Atefeh Sadeghi (21253051)

    Published 2025
    “…AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate. …”
  14. 614

    Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

    Published 2025
    “…Results are presented as mean ± SD. Ceramide: CER, Evogliptin: EVO. *(P < 0.05) significant vs. control group; <sup>$</sup>(P < 0.05) significant vs. …”
  15. 615
  16. 616
  17. 617

    NLSs can significantly impact intranuclear stages of HIV-1 infection. by Nicholas Rohlfes (20577485)

    Published 2025
    “…Results in A,B,D and F (mean ± SEM) are representative from 3 independent experiments with at least technical duplicates. …”
  18. 618
  19. 619
  20. 620